Adherence to amiodarone monitoring recommendations before and after implementation of a centralized pharmacy service: A cohort study

Journal of Pharmacy Practice

Volumn 23, Issue 6, 2010, Pages 536-539

  Johnson, Samuel G ^a   Canty, Kara ^a   Billups, Sarah ^a   Schimmer, Jennifer ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

ambulatory care; cardiology; medication safety

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIODARONE; THYROTROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTROCARDIOGRAM; FEMALE; HEALTH CARE DELIVERY; HEART ARRHYTHMIA; HUMAN; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; THORAX RADIOGRAPHY; THYROID DISEASE;

EID: 78650194792     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190009358770     Document Type: Article

References (12)

1. Vassallo P., Trohman R. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007 ; 298 (11). 1312-1322.
2. Mattioni TA, Zheutlin TA, Sarmiento JJ, et al. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy. Ann Intern Med. 1989 ; 111 (7). 574-580.
3. Hunt S., Abraham W., Chin M., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation. 2005 ; 112 (12). e154 - e235.
4. Golschlager N., Epstein A., Naccarelli G., et al. A practical guide for clinicians who treat patients with amiodarone 2007. Heart Rhythm. 2007 ; 4 (9). 1250-1259.
5. Hilleman D., Miller MA, Parker R., et al. Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy. 1998 ;18(6 pt 2): 138S - 145S.
6. Singh B. Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy. Clin Cardiol. 1997 ; 20 (7). 608-618.
7. Campbell TJ, Williams KM Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol. 1998 ; 46 (4). 307-319.
8. Stelfox HT, Ahmed SB, Fiskio J., et al. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther. 2004 ; 75 (1). 110-122.
9. Marcel Gosselink AT, Crijns HG, Van Gelder IC, et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 1992 ; 267 (24). 3289-3293.
10. Naranjo CA, Busto U., Sellers M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 ; 30 (2). 239-245. (Pubitemid 12149145)
11. Graham MR, Wright MA, Manley H. Effectiveness of an amiodarone protocol and management clinic in improving adherence to amiodarone monitoring guidelines. J Pharm Technol. 2004 ; 20 (1). 5-10.
12. Sanoski CA, Schoen MD, Gonzalez RC, et al. Rationale, development and clinical outcomes of a multidisciplinary amiodarone clinic. Pharmacotherapy. 1998 ; 18 (6 pt 2). 146S - 151S.